Bryan J. Dicken

Bryan J. Dicken

Auto-generated profile, based on publicly available information

Bryan J. Dicken

Stollery Children's Hospital Edmonton Alberta Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
BDBryan J. Dicken
Bryan J. Dicken
Consolato SergiConsolato Sergi
Consolato Sergi
FRFrederick J. Rescorla
Frederick J. Rescorla
FBFrancine Breckler
Francine Breckler
DSDavid Sigalet
David Sigalet

1 March 2016 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
CMClaire McNiven
Claire McNiven
NSNoah Switzer
Noah Switzer
MWMelisssa Wood
Melisssa Wood
RPRabin Persad
Rabin Persad
MHMarie Hancock
Marie Hancock
BDBryan J. Dicken
Bryan J. Dicken

1 July 2014 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
JPJean-Sébastien Pelletier
Jean-Sébastien Pelletier
BDBryan Dicken
Bryan Dicken
DBDavid Bigam
David Bigam
PCPo-Yin Cheung
Po-Yin Cheung
Vasopressin is an essential hormone involved in the maintenance of cardiovascular homeostasis. It has been in use therapeutically for many decades, with an emphasis on its vasoconstrictive and antidiuretic properties. However, this hormone has a ubiquitous influence and has specific effects on the heart. Although difficult to separate from its powerful vascular effects in the clinical setting, a better understanding of vasopressin's direct cardiac effects could lead to its more effective clinical use for a variety of shock states by maximizing its therapeutic benefit. The cardiac-specific effects of vasopressin are complex and require further elucidation. Complicating our understanding include the various receptors and secondary messengers involved in vasopressin's effects, which may lead to various results based on differing doses and varying environmental conditions. Thus, there have been contradictory reports on vasopressin's action on the coronary vasculature and on its effect on inotropy. However, beneficial results have been found and warrant further study to expand the potential therapeutic role of vasopressin. This review outlines the effect of vasopressin on the coronary vasculature, cardiac contractility, and on hypertrophy and cardioprotection. These cardiac-specific effects of vasopressin represent an interesting area for further study for potentially important therapeutic benefits.

14 July 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
RBRoma Bhuta
Roma Bhuta
RSRachana Shah
Rachana Shah
JGJoanna J. Gell
Joanna J. Gell
JPJenny N. Poynter
Jenny N. Poynter
ABAditya Bagrodia
Aditya Bagrodia
FSFurqan Shaikh
Furqan Shaikh

29 December 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
BDBryan J. Dicken
Bryan J. Dicken
DBDeborah F. Billmire
Deborah F. Billmire
MKMark Krailo
Mark Krailo
CXCaihong Xia
Caihong Xia
FSFurqan Shaikh
Furqan Shaikh
AFA. Lindsay Frazier
A. Lindsay Frazier

1 March 2014 in The Journal of Pediatrics
Verified
Journal Article
Closed access
BDBryan J. Dicken
Bryan J. Dicken
ABAisha Bruce
Aisha Bruce
TSTarah M. Samuel
Tarah M. Samuel
PWPaul W. Wales
Paul W. Wales
SNSusan Nahirniak
Susan Nahirniak
JTJustine M. Turner
Justine M. Turner